Diagnostic accuracy of an uncorrected native T1 mapping sequence for liver fibrosis and inflammation in autoimmune hepatitis: a prospective study using histopathology as reference standard
- PMID: 39106024
- DOI: 10.1007/s11547-024-01863-2
Diagnostic accuracy of an uncorrected native T1 mapping sequence for liver fibrosis and inflammation in autoimmune hepatitis: a prospective study using histopathology as reference standard
Abstract
Purpose: There is an unmet clinical need for non-invasive imaging biomarkers that could replace liver biopsy in the management of patients with autoimmune hepatitis (AIH). In this study, we sought to evaluate the diagnostic accuracy of a simple uncorrected, non-contrast T1 mapping for detecting fibrosis and inflammation in AIH patients using histopathology as a reference standard.
Material and methods: Over 3 years, 33 patients with AIH were prospectively studied using a multiparametric liver MRI protocol which included T1 mapping. Biopsies were performed up to 3 months before imaging, and a standardized histopathological score for fibrosis (F0-F4) and inflammatory activity (PPA0-4) was used as a reference. Statistical analysis included independent t test, Mann-Whitney U-test, and ROC (receiver operating characteristic) analysis.
Results: T1 mapping values were significantly higher in patients with advanced fibrosis (F0-2 vs. F3-4; p < 0.015), significant fibrosis (F0-1 vs. F2-4; p < 0.005), and significant inflammatory activity (PPA 0-1 vs. PPA 2-4 p = 0.048). Moreover, the technique demonstrated a good diagnostic performance in detecting significant (AUC 0.856) and advanced fibrosis (AUC 0.835), as well as significant inflammatory activity (AUC 0.763).
Conclusion: A rapid, simple, uncorrected, non-contrast T1 mapping sequence showed satisfactory diagnostic performance in comparison with histopathology for detecting significant tissue inflammation and fibrosis in AIH patients, being a potential non-invasive imaging biomarker for monitoring disease activity in such individuals.
Keywords: Autoimmune hepatitis; Chronic hepatitis; Diagnostic imaging; Multiparametric magnetic resonance imaging.
© 2024. Italian Society of Medical Radiology.
References
-
- Ilyas JA, O’Mahony CA, Vierling JM (2011) Liver transplantation in autoimmune liver diseases. Best Pract Res Clin Gastroenterol 25:765–782. https://doi.org/10.1016/j.bpg.2011.09.008 - DOI - PubMed
-
- Manns MP, Czaja AJ, Gorham JD, Krawitt EL, Mieli-Vergani G, Vergani D, Vierling JM (2010) Diagnosis and management of autoimmune hepatitis. Hepatology 51:2193–2213. https://doi.org/10.1002/hep.23584 - DOI - PubMed
-
- Gomes NBN, Torres US, Ferraz MLCG, D’Ippolito G (2021) Autoimmune hepatitis in practice, from diagnosis to complications: what is the role of imaging? A clinicoradiological review. Clin Imaging 74:31–40. https://doi.org/10.1016/j.clinimag.2020.12.032 - DOI - PubMed
-
- Thomaides-Brears HB, Alkhouri N, Allende D, Harisinghani M, Noureddin M, Reau NS, French M, Pantoja C, Mouchti S, Cryer DRH (2022) Incidence of complications from percutaneous biopsy in chronic liver disease: a systematic review and meta-analysis. Dig Dis Sci 67:3366–3394. https://doi.org/10.1007/s10620-021-07089-w - DOI - PubMed
-
- Bedossa P, Carrat F (2009) Liver biopsy: the best, not the gold standard. J Hepatol 50:1–3. https://doi.org/10.1016/j.jhep.2008.10.014 - DOI - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
